Stoke Therapeutics Inc buy BTIG Research
Start price
18.08.25
/
50%
€15.60
Target price
18.08.26
€23.93
Performance (%)
84.62%
Price
17.10.25
€28.80
Summary
This prediction is currently active. With a performance of 84.62% the BUY prediction by BTIG_Research is a big success. This prediction currently runs until 18.08.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 10.769% | 10.769% |
| iShares Core DAX® | -1.072% | 2.415% |
| iShares Nasdaq 100 | 1.923% | 3.851% |
| iShares Nikkei 225® | 4.414% | 6.958% |
| iShares S&P 500 | 1.247% | 2.390% |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) was given a new $28.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
14.10.25
14.10.25
€33.70
14.10.26
14.10.26
8.27%
17.10.25
17.10.25
